Below are the financial statements of BioMarin Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenues | — | — | — |
| Net product revenues | 2,809.45a | 2,372.54a | 2,042.03a |
| Royalty and other revenues | 44.47a | 46.69a | 54.01a |
| Total revenues | 2,853.92a | 2,419.23a | 2,096.04a |
| Operating expenses | — | — | — |
| Cost of sales | -580.24a | -532.06a | -503.02a |
| Research and development | -747.18a | -746.77a | -649.61a |
| Selling, general and administrative | -1,009.03a | -892.41a | -823.24a |
| Intangible asset amortization | -43.26a | -62.21a | -67.19a |
| Gain on sale of nonfinancial assets | -10a | 0a | -108a |
| Total operating expenses | -2,369.7a | -2,233.45a | -1,935.07a |
| Income from operations | 484.21a | 185.77a | 160.97a |
| Interest income | 74.88a | 58.34a | 18.03a |
| Interest expense | -12.67a | -17.34a | -15.97a |
| Other expense, net | -4.67a | -38.22a | -13.46a |
| Income before income taxes | 541.76a | 188.56a | 149.58a |
| Provision for income taxes | -114.9a | -20.92a | -8.02a |
| Net income | 426.86a | 167.65a | 141.56a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore BioMarin Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.